The Brain Cancer Program, in partnership with the Center for Music and Medicine at Johns Hopkins, will study whether music therapy is feasible in newly diagnosed GBM patients undergoing standard care.
Glioblastoma (Newly Diagnosed)
Cognitive capacity to respond to surveys
Access to computer and web access
Ability to attend virtual music therapy sessions
Not planning to undergo standard of care radiation therapy and concurrent and adjuvant temozolomide.
A life expectancy of less than 6 months.
Concurrent use of any other standard or investigational agents (excepting tumor treating fields).
Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection or psychiatric illness/social situations that would limit adherence with study requirements.
Parallel
Music intervention
Other interventionEach GBM study participant in Arm A will receive two 30-minute live synchronous virtual music therapy sessions per week for a period of 8 weeks to be curated by a board-certified music therapist. Arm B participants will receive curated playlists of music created by a music therapist. Participants will then listen to the curated music playlists on the participant's own device twice per week. All participants will complete a total of 16 music therapy sessions, scheduled twice per week over 8 weeks. Each session will last approximately 30 minutes.
Success rate of Music Therapy intervention for GBM patients
Determine success rate of the delivery of individualized virtual music therapy (MT) in participants undergoing standard of care treatment for newly diagnosed glioblastoma.
Rate of survey completion
Rate of participants completing all surveys.
Click on the lead sponsor to view all of their trials.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Lead sponsor
Keep Punching Foundation
Collaborator
